Apellis Pharmaceuticals Announces Merger With Biogen, Delisting from Nasdaq, and Convertible Notes Repurchase/Conversion Options
Apellis Pharmaceuticals Announces Merger with Biogen Inc. an...
Sign in to continue:
Apellis Pharmaceuticals Announces Merger with Biogen Inc. an...
AIM ImmunoTech Shares Positive Ampligen Data in Pancreatic C...
Cycurion Q1 2026 Earnings Report: Key Investor Insights ...
Senti Biosciences Q1 2026 Financial Report: Key Highlights f...
Dogwood Therapeutics Q1 2026 Financial Results: Key Investor...
Evolution Metals & Technologies Corp. Announces Major Capaci...
M-tron Industries, Inc. Files Investor Day Presentation and ...
Xponential Fitness, Inc. Announces Departure of Chief Operat...
Waste Management, Inc. (NYSE: WM) – Key Developments from An...
CAMP4 Therapeutics Presents Promising Preclinical Data on CM...